Jennifer Munkley

Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom.

Azur Environmental provides analytical systems for monitoring water. The company was founded on December 18, 1984 and is headquartered in Carlsbad, CA.

GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom.

Fios Genomics Ltd. provides genomic and bioinformatics data analysis services. It offers access to a combined resource of in-house bioinformaticians, statisticians and biologists working together to analyze, interpret genomic, transcriptomic and proteomic data. The company was founded by Peter Ghazal in 2008 and is headquartered in Edinburgh, the United Kingdom.

Arrayjet Ltd. develops and produces microarray printing technologies for researchers, drug development groups, and diagnostic companies. Its products include Sprint, Marathon and Super Marathon, Ultra Marathon I and II Microarrayers. The company was founded by Howard John Manning, Peter Ghazal and Douglas Roy in 2000 and is headquartered in Roslin, the United Kingdom.

Arquer Diagnostics Ltd. develops proprietary diagnostic immunoassays for the detection of prostate and bladder cancer using urine samples. Its develops non-invasive, urine-based ELISA and Point-of Care tests meet the increased demand for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes. The firm will commercialise ELISA and point-of-care urine tests for prostate and bladder cancer for use in the urology clinic, hospital lab and the GP’s surgery. The company was founded by David Nicholas Miller-Jones and William Dawson in 2007 and is headquartered in Sunderland, the United Kingdom.

The Pirbright Institute, founded in 1914, is based in Woking, UK. The institute specializes in preventing and controlling viral diseases of livestock and those that spread from animals to people. The British company's facilities and capabilities provide opportunities for collaboration with other institutes and industries in research, data analysis, training, and access to some areas on-site. The institute offers a range of products, including positive sera, inactivated antigens, diagnostic kits, viral cultures, and live midges. The non-profit company's high containment facilities are internationally groundbreaking in design and maintenance, and they provide consultancy in architecture, engineering, and highly specialized expertise in risk and assurance. The diagnostic development team works with the world reference laboratory for foot-and-mouth disease at the Pirbright Institute and external partners to provide diagnostic products for foot-and-mouth disease (FMD), swine vesicular disease (SVD), and peste des petit ruminants (PPR).

Hologic Ltd. manufactures life sciences products and services with two divisions, Molecular Diagnostics and Research Products & Services. The firm has laboratories, manufacturing and operations in the USA, UK and France. It provides test kits, reagents and services to two synergistic markets. It focuses on these niche opportunities with products, patents, expertise and acquisitions. The company was founded in 1992 and is headquartered in Wythenshawe, the United Kingdom.